Cargando…

Urinary Tract Infections: Treatment/Comparative Therapeutics

Urinary tract infection (UTI) occurs when there is compromise of host defense mechanisms and a virulent microbe adheres, multiplies, and persists in a portion of the urinary tract. Most commonly, UTI is caused by bacteria, but fungi and viruses are possible. Urine culture and sensitivity are the gol...

Descripción completa

Detalles Bibliográficos
Autores principales: Olin, Shelly J., Bartges, Joseph W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114653/
https://www.ncbi.nlm.nih.gov/pubmed/25824394
http://dx.doi.org/10.1016/j.cvsm.2015.02.005
_version_ 1783513933857947648
author Olin, Shelly J.
Bartges, Joseph W.
author_facet Olin, Shelly J.
Bartges, Joseph W.
author_sort Olin, Shelly J.
collection PubMed
description Urinary tract infection (UTI) occurs when there is compromise of host defense mechanisms and a virulent microbe adheres, multiplies, and persists in a portion of the urinary tract. Most commonly, UTI is caused by bacteria, but fungi and viruses are possible. Urine culture and sensitivity are the gold standards for diagnosis of bacterial UTI. Identifying the location of infection (eg, bladder, kidney, prostate) as well as comorbidities (eg, diabetes mellitus, immunosuppression) is essential to guide the diagnostic and therapeutic plan. Antimicrobial agents are the mainstay of therapy for bacterial UTI and selected ideally based on culture and sensitivity.
format Online
Article
Text
id pubmed-7114653
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71146532020-04-02 Urinary Tract Infections: Treatment/Comparative Therapeutics Olin, Shelly J. Bartges, Joseph W. Vet Clin North Am Small Anim Pract Article Urinary tract infection (UTI) occurs when there is compromise of host defense mechanisms and a virulent microbe adheres, multiplies, and persists in a portion of the urinary tract. Most commonly, UTI is caused by bacteria, but fungi and viruses are possible. Urine culture and sensitivity are the gold standards for diagnosis of bacterial UTI. Identifying the location of infection (eg, bladder, kidney, prostate) as well as comorbidities (eg, diabetes mellitus, immunosuppression) is essential to guide the diagnostic and therapeutic plan. Antimicrobial agents are the mainstay of therapy for bacterial UTI and selected ideally based on culture and sensitivity. Elsevier Inc. 2015-07 2015-03-29 /pmc/articles/PMC7114653/ /pubmed/25824394 http://dx.doi.org/10.1016/j.cvsm.2015.02.005 Text en Copyright © 2015 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Olin, Shelly J.
Bartges, Joseph W.
Urinary Tract Infections: Treatment/Comparative Therapeutics
title Urinary Tract Infections: Treatment/Comparative Therapeutics
title_full Urinary Tract Infections: Treatment/Comparative Therapeutics
title_fullStr Urinary Tract Infections: Treatment/Comparative Therapeutics
title_full_unstemmed Urinary Tract Infections: Treatment/Comparative Therapeutics
title_short Urinary Tract Infections: Treatment/Comparative Therapeutics
title_sort urinary tract infections: treatment/comparative therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114653/
https://www.ncbi.nlm.nih.gov/pubmed/25824394
http://dx.doi.org/10.1016/j.cvsm.2015.02.005
work_keys_str_mv AT olinshellyj urinarytractinfectionstreatmentcomparativetherapeutics
AT bartgesjosephw urinarytractinfectionstreatmentcomparativetherapeutics